Not Yet RecruitingNCT06843187

Lemborexant for the Treatment of Residual Insomnia in Major Depressive Disorder (MDD)

This not yet recruiting study focuses on depression and currently lists sites or participation links in Canada.

DepressionOtherFrom 18 Years to 70 Years

In plain English

Key information made simple

This study exists to see whether a digital app or remote support tool can make care clearer and more responsive. Researchers are trying to understand whether a digital app or remote support tool can improve sleep, daily rhythms, and longer-term stability. For people living with Depression, access and fit can matter just as much as the treatment itself. If the findings are useful, they could help shape larger studies and better designed support in the future. Taking part helps build the evidence that can improve understanding and care for others over time.

What to expect

Your next step

The official record suggests in-person participation through a hospital, with sites including St Michael's Hospital, Unity Health Toronto in Toronto. Participation appears to involve questionnaires, interviews, or regular check-ins about day-to-day experience. The main fit is usually matching the main diagnosis, while common reasons not to take part include active substance or alcohol problems that could affect the results and pregnancy or breastfeeding. This is an early-stage study, which usually means a smaller group and a focus on learning how the approach behaves.

Official source

Registry reference

This page links back to the public source record so people can verify details directly with the registry and research team.

If you want the full study description, eligibility criteria, locations, and sponsor information in the original format, this is the place to check before taking the next step.

Open source record

Interested?

Check my eligibility

Study reference: NCT06843187. Your email is the only field you need to provide here.

In practice

For you

Taking part may help improve understanding of your condition.

It requires regular follow-up, often through questionnaires or interviews.

Requires travel, with in-person participation in Canada.

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com